Please use this identifier to cite or link to this item:
https://open.uns.ac.rs/handle/123456789/7443
Title: | Gadolinium-based imaging contrast agents | Authors: | Milić, Neda Preradović N. Milošević, Nataša Vučaj Ćirilov, Viktorija Till, Viktor |
Issue Date: | 1-Jan-2014 | Journal: | Current Medical Imaging Reviews | Abstract: | The contrast agents have been developed to enhance and improve the quality of images in radiology practice in order to define the physiology and pathophysiology in various tissues, to detect and define neoplastic, inflammatory and functional abnormalities. Most contrast agents for magnetic resonance imaging approved for human applications are gadolinium-based. Paramagnetic chelates containing lanthanide ion, gadolinium (III), are generally used as contrast agents (CAs) for diagnostic imaging. The gadolinium-based contrast agents (GBCAs) are mostly approved by the FDA for an intravenous (IV) administration in radiology imaging as they can provide greater contrast between normal and abnormal tissues within the body. The aim of this review is to underline the chemistry and usage of nine GBCAs which are currently approved for the use in the Western countries and to point out some novel GBCAs for the magnetic resonance imaging (MRI) and for the magnetic resonance angiography (MRA). © 2014 Bentham Science Publishers. | URI: | https://open.uns.ac.rs/handle/123456789/7443 | ISSN: | 15734056 | DOI: | 10.2174/157340561002140715103638 |
Appears in Collections: | MDF Publikacije/Publications |
Show full item record
SCOPUSTM
Citations
1
checked on May 3, 2024
Page view(s)
36
Last Week
14
14
Last month
0
0
checked on May 10, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.